Literature DB >> 15954892

Pathophysiology of contrast medium-induced nephropathy.

Pontus B Persson1, Peter Hansell, Per Liss.   

Abstract

BACKGROUND: Contrast medium-induced nephropathy (CIN) is a well-known cause of acute renal failure, but the development of CIN remains poorly understood. A number of studies have been performed with the one aim, to shed some light onto the pathophysiology of CIN. These have led to manifold interpretations and sometimes contradicting conclusions.
METHODS: This review critically surveys mechanisms believed to mediate CIN by highlighting the complex pathophysiologic entity, including altered rheologic properties, perturbation of renal hemodynamics, regional hypoxia, auto- and paracrine factors [adenosine, endothelin, and reactive oxygen species (ROS)], and direct cytotoxic effects. Moreover, the importance of physicochemical properties of contrast media are made clear.
RESULTS: The more recently developed iso-osmolar contrast media are dimers, not monomers as the widely used nonionic low osmolar contrast media. The dimers have physicochemical features different from other contrast media which may be of clinical importance, not only with respect to osmolality. The viscosity of the commercially available dimers is considerably higher than blood.
CONCLUSION: Many experimental studies provide evidence for a greater perturbation in renal functions by dimeric contrast media in comparison to nonionic monomeric contrast media. Clinical trials have yielded conflicting results.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15954892     DOI: 10.1111/j.1523-1755.2005.00377.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  115 in total

1.  Prolonged carotid sinus reflex is a risk factor for contrast-induced nephropathy following carotid artery stenting.

Authors:  T Kato; H Sakai; M Tsujimoto; Y Nishimura
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-27       Impact factor: 3.825

2.  Protective effect of beta-glucan on contrast induced-nephropathy and a comparison of beta-glucan with nebivolol and N-acetylcysteine in rats.

Authors:  Eyup Koc; Kadriye Altok Reis; Fatma Ayerden Ebinc; Hatice Pasaoglu; Canan Demirtas; Suna Omeroglu; Ulver Boztepe Derici; Galip Guz; Yasemin Erten; Musa Bali; Turgay Arinsoy; Sukru Sindel
Journal:  Clin Exp Nephrol       Date:  2011-04-26       Impact factor: 2.801

3.  Using intravoxel incoherent motion MR imaging to study the renal pathophysiological process of contrast-induced acute kidney injury in rats: Comparison with conventional DWI and arterial spin labelling.

Authors:  Long Liang; Wen-Bo Chen; Kannie W Y Chan; Yu-Guo Li; Bin Zhang; Chang-Hong Liang; Guan-Shu Liu; Shui-Xing Zhang
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

4.  Comparison of magnetic wire navigation with the conventional wire technique for percutaneous coronary intervention of chronic total occlusions: a randomised, controlled study.

Authors:  Christian Roth; Rudolf Berger; Sabine Scherzer; Lisa Krenn; Clemens Gangl; Daniel Dalos; Georg Delle-Karth; Thomas Neunteufl
Journal:  Heart Vessels       Date:  2015-09-14       Impact factor: 2.037

5.  Protective effect of salidroside on contrast-induced nephropathy in comparison with N-acetylcysteine and its underlying mechanism.

Authors:  Yue Xing; Ri-bao Wei; Lu Tang; Yue Yang; Xiao-yong Zheng; Zi-cheng Wang; Yu-wei Gao
Journal:  Chin J Integr Med       Date:  2015-04-16       Impact factor: 1.978

Review 6.  Contrast-induced acute kidney injury and diabetic nephropathy.

Authors:  Andrew D Calvin; Sanjay Misra; Axel Pflueger
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

Review 7.  Contrast-induced acute kidney injury in interventional cardiology: Emerging evidence and unifying mechanisms of protection by remote ischemic conditioning.

Authors:  Adebayo C Atanda; Oladipupo Olafiranye
Journal:  Cardiovasc Revasc Med       Date:  2017-06-06

Review 8.  Contrast-induced nephropathy; A literature review.

Authors:  Jafar Golshahi; Hamid Nasri; Mojgan Gharipour
Journal:  J Nephropathol       Date:  2014-04-01

9.  Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials.

Authors:  Xue-Biao Wei; Lei Jiang; Xin-Rong Liu; Dan-Qing Yu; Ning Tan; Ji-Yan Chen; Ying-Ling Zhou; Peng-Cheng He; Yuan-Hui Liu
Journal:  Eur J Clin Pharmacol       Date:  2016-10-01       Impact factor: 2.953

10.  Atrial natriuretic peptide for the prevention of contrast-induced nephropathy: what's old is new but at the right dose and duration of therapy!

Authors:  Horng H Chen
Journal:  J Am Coll Cardiol       Date:  2009-03-24       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.